Article
In vivo mouse models for adult brain tumors: Exploring tumorigenesis and advancing immunotherapy development
11 Jul 2024
Abstract excerpt
Brain tumors, particularly glioblastoma (GBM), are devastating and challenging to treat, with a low 5-year survival rate of only 6.6%. Mouse models are established to understand tumorigenesis and develop new therapeutic strategies. Large-scale genomic studies have facilitated the identification of genetic alterations driving human brain tumor development and progression. Genetically engineered mouse models...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
